5-[[4-[4-(cyanomethoxy)-3-methylanilino]-5-fluoropyrimidin-2-yl]amino]-2-fluorobenzenesulfonamide
C19H16F2N6O3S — CID 15605546
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[[4-[4-(cyanomethoxy)-3-methylanilino]-5-fluoropyrimidin-2-yl]amino]-2-fluorobenzenesulfonamide
5-[[4-[4-(cyanomethoxy)-3-methylanilino]-5-fluoropyrimidin-2-yl]amino]-2-fluorobenzenesulfonamide (PubChem CID 15605546) has the molecular formula C19H16F2N6O3S and a molecular weight of 446.44 g/mol. Its IUPAC name is 5-[[4-[4-(cyanomethoxy)-3-methylanilino]-5-fluoropyrimidin-2-yl]amino]-2-fluorobenzenesulfonamide.
Molecular Properties
| Compound Name | 5-[[4-[4-(cyanomethoxy)-3-methylanilino]-5-fluoropyrimidin-2-yl]amino]-2-fluorobenzenesulfonamide |
|---|---|
| PubChem CID | 15605546 |
| Molecular Formula | C19H16F2N6O3S |
| Molecular Weight | 446.44 g/mol |
| Exact Mass | 446.10 |
| IUPAC Name | 5-[[4-[4-(cyanomethoxy)-3-methylanilino]-5-fluoropyrimidin-2-yl]amino]-2-fluorobenzenesulfonamide |
| SMILES | Cc1cc(Nc2nc(Nc3ccc(F)c(S(N)(=O)=O)c3)ncc2F)ccc1OCC#N |
| InChI | InChI=1S/C19H16F2N6O3S/c1-11-8-12(3-5-16(11)30-7-6-22)25-18-15(21)10-24-19(27-18)26-13-2-4-14(20)17(9-13)31(23,28)29/h2-5,8-10H,7H2,1H3,(H2,23,28,29)(H2,24,25,26,27) |
| InChIKey | KGHGJALZZOPPLV-UHFFFAOYSA-N |
| XLogP | 3.10 |
| TPSA | 143.02 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 446.44 |
| LogP ≤ 5 | 3.10 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 15605546 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.